Reimagining Health Benefits: How Employers Can Drive Change in Healthcare
June 23, 2026
John D'Angelo, M.D. , President and CEO of Northwell Health joins A&M Healthcare Industry Group's Jamie LaGuardia-Frie and David Shulkin, M.D. to explore how health systems can move beyond fragmented care delivery to create a model where patients feel supported across every step of their journey.
Leapfrogging Your Health System’s Enterprise Shared Services (ESS) Organization to Accelerate Value
May 7, 2026
Redesign admin work with an ESS to standardize, govern, and deliver at scale: Cut costs, boost productivity, and strengthen long-term business viability.
The Next Growth Curve: How Biopharma Can Win in Developing Markets
April 20, 2026
Developed markets are facing structural headwinds, such as affordability constraints, pricing reform, as demographic saturation and slower volume growth are limiting expansion and resulting a moderating growth rate. In contrast, emerging markets are entering a phase of healthcare formalization and access expansion driven by rising chronic disease burden and government prioritization of pharmaceuticals
Medicare Advantage at an Inflection Point: From Coding Arbitrage to Value Competition
February 9, 2026
The Trump administration’s 2027 Medicare Advantage (MA) Advance Notice triggered an immediate and violent market response—one that underscores how deeply investors understand the implications of this policy shift.